Moreno, Ana

Publishing since 1977 (Dinosaur)

Has published 413 publications in 34 years

Number of publications published per year by Moreno, Ana. (Source : PubMed)

Distribution of publications types for Moreno, Ana. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Lima-Junior JC, Banic DM, Tran TM, Meyer VS, De-Simone SG, Santos F, Porto LC, Marques MT, Moreno A, Barnwell JW, Galinski MR, Oliveira-Ferreira J. Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon.  Vaccine  2010;28;18  
•  Lincecum JM, Vieira FG, Wang MZ, Thompson K, De Zutter GS, Kidd J, Moreno A, Sanchez R, Carrion IJ, Levine BA, Al-Nakhala BM, Sullivan SM, Gill A, Perrin S. From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis.  Nat. Genet.  2010  
•  Singh B, Cabrera-Mora M, Jiang J, Galinski M, Moreno A. Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate.  Vaccine  2010;28;14  
•  Vispo E, Moreno A, Maida I, Barreiro P, Cuevas A, Albertos S, Soriano V. Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings.  AIDS  2010  
•  Gómez-Cabello D, Callejas S, Benguría A, Moreno A, Alonso J, Palmero I. Regulation of the microRNA processor DGCR8 by the tumor suppressor ING1.  Cancer Res.  2010;70;5  
•  Moreno A, Sánchez F, Nelson J, Miró JM, Caylà JA. [On the way to shortening tuberculosis treatments: clinical trials of the Unitat d' Investagació en Tuberculosi de Barcelona supported by the Centers for Disease Control and Prevention.]  Gac Sanit  2010;24;2  
•  Echeverría P, Negredo E, Carosi G, Gálvez J, Gómez JL, Ocampo A, Portilla J, Prieto A, López JC, Rubio R, Mariño A, Pedrol E, Viladés C, del Arco A, Moreno A, Bravo I, López-Blazquez R, Pérez-Alvarez N, Clotet B. Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).  Antiviral Res.  2010;85;2  
•  Gallego S, Llort A, Gros L, Sanchez de Toledo J, Bueno J, Moreno A, Nieto J, Sanchez de Toledo J. Post-transplant lymphoproliferative disorders in children: the role of chemotherapy in the era of rituximab.  Pediatr Transplant  2010;14;1  
•  Moreno A, Pérez-Elías MJ, Casado JL, Fortún J, Bárcena R, Quereda C, Del Campo S, Gutiérrez C, Pastor O, Nuño J, Fernandez A, Moreno S. Raltegravir-based highly active antiretroviral therapy has beneficial effects on the renal function of human immunodeficiency virus-infected patients after solid organ transplantation.  Liver Transpl.  2009  
•  Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L, Babini A, Moreno A, D'Cruz D, Khamashta MA. Clinical guidelines for the management of acute viral infections in patients with systemic lupus erythematosus.  Minerva Med.  2009;100;6  

[ See timeline ] [ See all publications ]